Taken together, it has been shown in this study that FLRT2 expression is suppressed in breast cancer as a result of hypermethylation at promoter CpG sites, which is related to an unfavorable prognosis in cancer patients. The gene discussed is FLRT2; the disease is breast carcinoma.